Evommune Email Formats
Contact top employees from
Evommune
- Evommune uses 6 different email formats. The most common is lastNamefirstName (for example, doejane@evommune.com), which appears in about 34% of work addresses.
- Other common patterns include:
- firstName.lastNameInitial: jane.d@evommune.com (21%)
- firstNamelastNameInitial: janed@evommune.com (24%)
Evommune’s Popular Email Formats
| Format | Example | Percentage |
|---|---|---|
Format lastNamefirstName |  doejane@evommune.com | Percentage: 34% |
Format firstNamelastNameInitial | janed@evommune.com | Percentage: 24% |
Format firstName.lastNameInitial | jane.d@evommune.com | Percentage: 21% |
Format lastName | doe@evommune.com | Percentage: 10% |
Format firstNameInitial-lastNameInitial | j-d@evommune.com | Percentage: 10% |
Format lastNameInitialfirstNameInitial | dj@evommune.com | Percentage: 1% |
Contact top employees from
Evommune
Jane HaSenior Manager, Finance
Email (4)*h*@grantthornton.com
, *h*@gt.com
, j*****a@kadmon.com
, ...
Phone (4)+1-323-***-**33
, +1-480-***-**81
, ...
Kyle CarverChief Financial Officer
Email (3)k*********r@kadmon.com
, k*********r@evommune.com
, k******0@gmail.com
Phone (2)+1-623-***-**62
, +1-909-***-**75
Lou SehlSenior Vice President, Technical Operations
Email (2)s***@medicines360.org
, s***@yahoo.com
Phone (4)+1-623-***-**81
, +1-323-***-**30
, ...
Kelsey SantistebanSenior Clinical Trial Manager
Email (3)s***@aol.com
, k***@uoregon.edu
, k***@annexonbio.com
Phone (3)+1-870-***-**17
, +1-323-***-**29
, ...
Madeleine BeagleSenior Executive Assistant to Chief Executive Officer
Email (5)m**************e@gallo.com
, m*********e@evommune.com
, m**************e@evommune.com
, ...
Phone (4)+1-870-***-**11
, +1-480-***-**49
, ...
Jeegar PatelChief Scientific Officer
Email (2)j**********l@evommune.com
, j**********l@gmail.com
Phone (1)+1-***-***-3395
Mark JacksonSenior Vice President of Clinical Development
Email (6)m**********n@forefrontderm.com
, m**********n@evommune.com
, m******n@forefrontdermatology.com
, ...
Phone (1)+1-***-***-3184
Alex BrehmController, Senior Director, Finance
Email (4)a****m@deloitte.com
, a********m@kadmon.com
, a********m@evommune.com
, ...
Phone (1)+1-***-***-9068
Derek KuwaharaSenior Director Business Development
Email (6)d*******a@lacounty.gov
, d*******a@catbio.com
, d************a@codexis.com
, ...
Phone (1)+1-***-***-9832
Samantha SchumannHuman Resources Coordinator
Email (6)s******a@poshmark.com
, s*******n@wtisllc.com
, s*******n@penumbrainc.com
, ...
Phone (1)+1-***-***-9674
Julia KongDirector, Supply Chain
Email (5)j********g@gilead.com
, j***g@vir.bio
, j********g@gene.com
, ...
Phone (1)+1-***-***-5366
Robert WhitenerSenior Scientist I
Email (4)r*************r@evommune.com
, r*************r@gmail.com
, r********r@ufl.edu
, ...
Phone (1)+1-***-***-6158
Rachel HunterSenior Director, Human Resources (HR Business Partner)
Email (6)r****l@barefootnetworks.com
, h**********l@loon.com
, r*****r@loon.com
, ...
Phone (1)+1-***-***-9358
0% completed
Verify Evommune Business Emails
Evommune employee email verification for instant deliverability checks.Companies Similar to Evommune
Evommune Corporate Information: FAQ
The company currently specializes in the Biotechnology area. The annual revenue of Evommune varies between 10M and 50M. To connect with Evommune employee register on SignalHire.
Evommune uses 6 email formats across its organization. The most common pattern is lastNamefirstName (e.g., doejane@evommune.com), used in approximately 34% of work addresses.
Evommune currently employs over 10-50 people from United States, with a head office in Palo Alto, California.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
